| Laura Ann Roach, PT | |
|
690 Minot Ave, Auburn, ME 04210-3922 | |
| (207) 783-3450 | |
| (207) 777-3979 |
| Full Name | Laura Ann Roach |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 690 Minot Ave, Auburn, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104143601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT3582 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saco Bay Orthopaedic And Sports Physical Therapy Inc | 9537069265 | 109 |
News Archive
A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumor growth and increasing survival in multiple myeloma tumor-bearing mice, according to new research published in the July issue of the Journal of Nuclear Medicine. Given the long half-life, central production and worldwide distribution of 212Pb-anti-CD38, researchers have determined that the α-radioimmunotherapy is not only effective but also clinically feasible as a multiple myeloma treatment.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.
Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, "Contactless Infant Monitoring using White Noise," at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.
A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
› Verified 3 days ago
| Provider Name | Saco Bay Orthopaedic And Sports Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1346254315 PECOS PAC ID: 9537069265 Enrollment ID: O20040109000951 |
News Archive
A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumor growth and increasing survival in multiple myeloma tumor-bearing mice, according to new research published in the July issue of the Journal of Nuclear Medicine. Given the long half-life, central production and worldwide distribution of 212Pb-anti-CD38, researchers have determined that the α-radioimmunotherapy is not only effective but also clinically feasible as a multiple myeloma treatment.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.
Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, "Contactless Infant Monitoring using White Noise," at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.
A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
› Verified 3 days ago
| Provider Name | Select Physical Therapy Holdings Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1427564590 PECOS PAC ID: 9537076401 Enrollment ID: O20180306000729 |
News Archive
A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumor growth and increasing survival in multiple myeloma tumor-bearing mice, according to new research published in the July issue of the Journal of Nuclear Medicine. Given the long half-life, central production and worldwide distribution of 212Pb-anti-CD38, researchers have determined that the α-radioimmunotherapy is not only effective but also clinically feasible as a multiple myeloma treatment.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.
Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, "Contactless Infant Monitoring using White Noise," at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.
A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Ann Roach, PT 690 Minot Ave, Auburn, ME 04210-3922 Ph: (207) 783-3450 | Laura Ann Roach, PT 690 Minot Ave, Auburn, ME 04210-3922 Ph: (207) 783-3450 |
News Archive
A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumor growth and increasing survival in multiple myeloma tumor-bearing mice, according to new research published in the July issue of the Journal of Nuclear Medicine. Given the long half-life, central production and worldwide distribution of 212Pb-anti-CD38, researchers have determined that the α-radioimmunotherapy is not only effective but also clinically feasible as a multiple myeloma treatment.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.
Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, "Contactless Infant Monitoring using White Noise," at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.
A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
› Verified 3 days ago
Rebecca Cobb, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 637 Minot Ave, Auburn, ME 04210 Phone: 207-783-3393 Fax: 207-783-0848 | |
Michael Cameron Duff, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 637 Minot Ave, Auburn, ME 04210 Phone: 207-783-3393 Fax: 207-783-0848 | |
Jason Burtchell, Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 32 Sunderland Dr, Auburn, ME 04210 Phone: 207-707-1409 Fax: 833-544-0823 | |
Susan Jewett, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 690 Minot Ave Ste 2, Auburn, ME 04210 Phone: 207-783-3450 | |
Jill Beaucage, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 690 Minot Ave, Suite Two, Auburn, ME 04210 Phone: 207-783-3450 | |
Jill Marie Cramp, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 690 Minot Avenue, Suite 2, Auburn, ME 04210 Phone: 207-783-3450 Fax: 207-777-3979 |